Abbott Laboratories buy Royal Bank of Canada
Start price
19.04.24
/
50%
€98.67
Target price
19.04.25
€117.41
Performance (%)
-3.29%
Price
22:26
€95.42
Summary
This prediction is currently active. With a performance of -3.29%, the BUY prediction for Abbott Laboratories by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 19.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | -1.512% | -1.512% |
iShares Core DAX® | -0.383% | 5.404% |
iShares Nasdaq 100 | 1.248% | 6.732% |
iShares Nikkei 225® | 0.525% | 1.840% |
iShares S&P 500 | 0.640% | 4.710% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
-7.90%
22:26
22:26
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
-6.44%
22:26
22:26
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-6.35%
22:26
22:26